Clarus Therapeutics Email Format
Pharmaceutical ManufacturingIllinois, United States11-50 Employees
Clarus Therapeutics is a privately held pharmaceutical manufacturer focused on men’s health, addressing hypogonadism through testosterone replacement therapy and related treatments. Based in Northbrook, Illinois, the company targets men with deficient or absent endogenous testosterone to improve related health outcomes. In October 2022, Tolmar Pharmaceuticals acquired Clarus Therapeutics to strengthen its urology and men’s health portfolio by adding JATENZO, a testosterone replacement therapy. The company has pursued collaborations to advance its therapies, including a 2022 partnership with Catalent Pharma Solutions to develop a new drug-delivery form for its hormone replacement therapy. It also launched an online patient portal in February 2022 in collaboration with Vault Health and AssistRx.